• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

补中益气方对肥胖型多囊卵巢综合征患者肠道菌群的影响

Impact of Buzhong Yiqi Prescription on the Gut Microbiota of Patients with Obesity Manifesting Polycystic Ovarian Syndrome.

作者信息

Ni Zhexin, Cheng Wen, Ding Jie, Yao Ruipin, Zhang Danying, Zhai Dongxia, Zhou Ling, Yu Chaoqin

机构信息

Department of Traditional Chinese Gynecology, Changhai Hospital, Naval Medical University, Shanghai 200433, China.

Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.

出版信息

Evid Based Complement Alternat Med. 2021 Mar 15;2021:6671367. doi: 10.1155/2021/6671367. eCollection 2021.

DOI:10.1155/2021/6671367
PMID:33790981
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7984899/
Abstract

Gut microbiota disorders are closely related to polycystic ovarian syndrome (PCOS). Buzhong Yiqi prescription (BZYQ) has a significant clinical effect on the treatment of patients with obesity exhibiting PCOS and phlegm-dampness syndrome caused by spleen deficiency (SPSD). Hence, this study aimed to explore gut microbiota and fecal metabolite alterations in such patients treated with BZYQ. Fifty eligible patients with obesity manifesting PCOS and SPSD participated and agreed to undergo 3 months of BZYQ treatment. Results showed that BZYQ significantly alleviated the serum dehydroepiandrosterone sulfate ( < 0.001) and testosterone levels ( < 0.001) and markedly changed the gut microbiota structure in these patients. Furthermore, 106 differential fecal metabolites and 14 KEGG enrichment pathways were quantified. The phylum Spirochaetae and the genera , , and were significantly more abundant, but was significantly less abundant after treatment than before treatment. Disorders in the gut microbiota and fecal metabolites of these patients were closely related to hyperandrogenemia and insulin resistance. In conclusion, BZYQ could ameliorate the serum androgen level and had an impact on the gut microbiota and metabolites in patients with obesity manifesting PCOS and SPSD.

摘要

肠道微生物群紊乱与多囊卵巢综合征(PCOS)密切相关。补中益气方(BZYQ)对治疗肥胖型PCOS及脾虚痰湿证(SPSD)患者具有显著临床疗效。因此,本研究旨在探讨BZYQ治疗此类患者后肠道微生物群和粪便代谢物的变化。50例符合条件的肥胖型PCOS及SPSD患者参与并同意接受3个月的BZYQ治疗。结果显示,BZYQ显著降低了血清硫酸脱氢表雄酮水平(<0.001)和睾酮水平(<0.001),并显著改变了这些患者的肠道微生物群结构。此外,还定量分析了106种差异粪便代谢物和14条KEGG富集通路。治疗后,螺旋体门以及、和属的丰度显著增加,但的丰度显著低于治疗前。这些患者的肠道微生物群和粪便代谢物紊乱与高雄激素血症和胰岛素抵抗密切相关。总之,BZYQ可改善血清雄激素水平,并对肥胖型PCOS及SPSD患者的肠道微生物群和代谢物产生影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2f8/7984899/28b1086c1ca3/ECAM2021-6671367.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2f8/7984899/108be90859a5/ECAM2021-6671367.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2f8/7984899/a8a1728069a7/ECAM2021-6671367.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2f8/7984899/e6981bbe11ff/ECAM2021-6671367.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2f8/7984899/823a479a41a6/ECAM2021-6671367.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2f8/7984899/151696d03474/ECAM2021-6671367.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2f8/7984899/28b1086c1ca3/ECAM2021-6671367.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2f8/7984899/108be90859a5/ECAM2021-6671367.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2f8/7984899/a8a1728069a7/ECAM2021-6671367.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2f8/7984899/e6981bbe11ff/ECAM2021-6671367.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2f8/7984899/823a479a41a6/ECAM2021-6671367.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2f8/7984899/151696d03474/ECAM2021-6671367.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2f8/7984899/28b1086c1ca3/ECAM2021-6671367.006.jpg

相似文献

1
Impact of Buzhong Yiqi Prescription on the Gut Microbiota of Patients with Obesity Manifesting Polycystic Ovarian Syndrome.补中益气方对肥胖型多囊卵巢综合征患者肠道菌群的影响
Evid Based Complement Alternat Med. 2021 Mar 15;2021:6671367. doi: 10.1155/2021/6671367. eCollection 2021.
2
Correlation Between Fecal Metabolomics and Gut Microbiota in Obesity and Polycystic Ovary Syndrome.肥胖与多囊卵巢综合征患者粪便代谢组学与肠道微生物群的相关性
Front Endocrinol (Lausanne). 2020 Sep 8;11:628. doi: 10.3389/fendo.2020.00628. eCollection 2020.
3
Protective effect of thyroid and restores of ovarian function of Buzhong Yiqi granule on experimental autoimmune thyroiditis in female rats.补中益气颗粒对实验性自身免疫性甲状腺炎雌性大鼠甲状腺及卵巢功能的保护作用。
J Tradit Chin Med. 2024 Apr;44(2):315-323. doi: 10.19852/j.cnki.jtcm.20240203.008.
4
The gut microbial composition in polycystic ovary syndrome with hyperandrogenemia and its association with steroid hormones.伴有高雄激素血症的多囊卵巢综合征患者的肠道微生物组成及其与甾体激素的关联
Front Cell Dev Biol. 2024 May 30;12:1384233. doi: 10.3389/fcell.2024.1384233. eCollection 2024.
5
Irisin alleviated the reproductive endocrinal disorders of PCOS mice accompanied by changes in gut microbiota and metabolomic characteristics.鸢尾素减轻了多囊卵巢综合征小鼠的生殖内分泌紊乱,同时伴有肠道微生物群和代谢组学特征的变化。
Front Microbiol. 2024 May 23;15:1373077. doi: 10.3389/fmicb.2024.1373077. eCollection 2024.
6
Impact of Visceral Obesity on Structural and Functional Alterations of Gut Microbiota in Polycystic Ovary Syndrome (PCOS): A Pilot Study Using Metagenomic Analysis.内脏肥胖对多囊卵巢综合征(PCOS)患者肠道微生物群结构和功能改变的影响:一项使用宏基因组分析的初步研究
Diabetes Metab Syndr Obes. 2023 Jan 11;16:1-14. doi: 10.2147/DMSO.S388067. eCollection 2023.
7
Alterations of Gut Microbiome and Fecal Fatty Acids in Patients With Polycystic Ovary Syndrome in Central China.中国中部多囊卵巢综合征患者肠道微生物群和粪便脂肪酸的变化
Front Microbiol. 2022 Jul 1;13:911992. doi: 10.3389/fmicb.2022.911992. eCollection 2022.
8
Interplay of Gut Microbiota in Polycystic Ovarian Syndrome: Role of Gut Microbiota, Mechanistic Pathways and Potential Treatment Strategies.肠道微生物群在多囊卵巢综合征中的相互作用:肠道微生物群的作用、作用机制途径及潜在治疗策略
Pharmaceuticals (Basel). 2023 Jan 28;16(2):197. doi: 10.3390/ph16020197.
9
Inulin and metformin ameliorate polycystic ovary syndrome via anti-inflammation and modulating gut microbiota in mice.菊粉和二甲双胍通过抗炎和调节肠道微生物群改善多囊卵巢综合征小鼠的症状。
Endocr J. 2019 Oct 28;66(10):859-870. doi: 10.1507/endocrj.EJ18-0567. Epub 2019 Jul 3.
10
Berberine regulates fecal metabolites to ameliorate 5-fluorouracil induced intestinal mucositis through modulating gut microbiota.小檗碱通过调节肠道微生物群来调节粪便代谢物,从而改善 5- 氟尿嘧啶诱导的肠道黏膜炎。
Biomed Pharmacother. 2020 Apr;124:109829. doi: 10.1016/j.biopha.2020.109829. Epub 2020 Jan 17.

引用本文的文献

1
Causal relationship between gut microbiota and androgenetic alopecia: A Mendelian randomization study.肠道微生物群与雄激素性脱发之间的因果关系:一项孟德尔随机化研究。
Medicine (Baltimore). 2024 Dec 27;103(52):e41106. doi: 10.1097/MD.0000000000041106.
2
The Effect of Prebiotics, Alone or as Part of Synbiotics, on Cardiometabolic Parameters in Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.益生元单独使用或作为合生元的一部分对多囊卵巢综合征女性心脏代谢参数的影响:一项随机对照试验的系统评价和荟萃分析
Biomedicines. 2025 Jan 13;13(1):177. doi: 10.3390/biomedicines13010177.
3

本文引用的文献

1
High-throughput sequencing study of the effect of transabdominal hysterectomy on intestinal flora in patients with uterine fibroids.高通量测序研究经腹子宫切除术对子宫肌瘤患者肠道菌群的影响。
BMC Microbiol. 2020 Apr 15;20(1):98. doi: 10.1186/s12866-020-01779-7.
2
Jianpi Huatan Tongfu granule alleviates inflammation and improves intestinal flora in patients with acute exacerbation of chronic obstructive pulmonary disease.健脾化痰通腑颗粒可减轻慢性阻塞性肺疾病急性加重期患者的炎症反应,改善肠道菌群。
J Int Med Res. 2020 Apr;48(4):300060520909235. doi: 10.1177/0300060520909235.
3
PKR inhibitors suppress endoplasmic reticulum stress and subdue glucolipotoxicity-mediated impairment of insulin secretion in pancreatic beta cells.
Microbial harmony in female reproductive health: exploring the impact of intestinal flora on ovarian function and disease pathogenesis.
女性生殖健康中的微生物和谐:探索肠道菌群对卵巢功能和疾病发病机制的影响。
Am J Transl Res. 2024 Nov 15;16(11):6274-6288. doi: 10.62347/GDNO7274. eCollection 2024.
4
Identification of the gut microbiota affecting and their relationship with reproductive performance in hens.影响母鸡生殖性能的肠道微生物群的鉴定及其与生殖性能的关系。
Front Microbiol. 2023 Jul 27;14:1216542. doi: 10.3389/fmicb.2023.1216542. eCollection 2023.
5
Effects of Yulin Tong Bu formula on modulating gut microbiota and fecal metabolite interactions in mice with polycystic ovary syndrome.育麟通补方对多囊卵巢综合征模型小鼠肠道菌群及其代谢物互作的影响
Front Endocrinol (Lausanne). 2023 Feb 6;14:1122709. doi: 10.3389/fendo.2023.1122709. eCollection 2023.
6
Past and present: a bibliometric study on polycystic ovary syndrome.过去与现在:多囊卵巢综合征的文献计量研究。
J Ovarian Res. 2023 Feb 18;16(1):42. doi: 10.1186/s13048-022-01072-3.
7
Polycystic Ovary Syndrome and Gut Microbiota: Phenotype Matters.多囊卵巢综合征与肠道微生物群:表型很重要。
Life (Basel). 2022 Dec 20;13(1):7. doi: 10.3390/life13010007.
8
The impact of herbal medicine in regulating intestinal flora on female reproductive disorders.草药调节肠道菌群对女性生殖系统疾病的影响。
Front Pharmacol. 2022 Oct 14;13:1026141. doi: 10.3389/fphar.2022.1026141. eCollection 2022.
9
Image Analysis of TVCDS in Infertile Patients with Polycystic Ovary Syndrome.多囊卵巢综合征不孕患者的 TVCDS 图像分析。
Contrast Media Mol Imaging. 2022 Jun 17;2022:1234983. doi: 10.1155/2022/1234983. eCollection 2022.
PKR抑制剂可抑制内质网应激,并减轻糖脂毒性介导的胰腺β细胞胰岛素分泌损伤。
Turk J Biol. 2020 Apr 2;44(2):93-102. doi: 10.3906/biy-1909-20. eCollection 2020.
4
Gut microbiota and Chinese medicine syndrome: altered fecal microbiotas in spleen (Pi)-deficient patients.肠道微生物群与中医证候:脾虚患者粪便微生物群的改变。
J Tradit Chin Med. 2020 Feb;40(1):137-143.
5
Depletion of Species in the Microbiota of Obese Children Relates to Intestinal Inflammation and Metabolic Phenotype Worsening.肥胖儿童微生物群中物种的耗竭与肠道炎症和代谢表型恶化有关。
mSystems. 2020 Mar 24;5(2):e00857-19. doi: 10.1128/mSystems.00857-19.
6
Pathophysiologic mechanisms of obesity- and chronic inflammation-related genes in etiology of polycystic ovary syndrome.肥胖及慢性炎症相关基因在多囊卵巢综合征病因学中的病理生理机制
Iran J Basic Med Sci. 2019 Dec;22(12):1378-1386. doi: 10.22038/IJBMS.2019.14029.
7
Exploration of the Relationship Between Gut Microbiota and Polycystic Ovary Syndrome (PCOS): a Review.肠道微生物群与多囊卵巢综合征(PCOS)关系的探讨:综述
Geburtshilfe Frauenheilkd. 2020 Feb;80(2):161-171. doi: 10.1055/a-1081-2036. Epub 2020 Feb 21.
8
Controversial conclusions from two randomized controlled trials for acupuncture's effects on polycystic ovary syndrome or in vitro fertilization support.两项关于针刺对多囊卵巢综合征或体外受精作用的随机对照试验的有争议的结论支持。
J Integr Med. 2020 Mar;18(2):89-91. doi: 10.1016/j.joim.2020.01.007. Epub 2020 Jan 21.
9
Characteristic gut microbiota and predicted metabolic functions in women with PCOS.多囊卵巢综合征女性的特征性肠道微生物群及预测的代谢功能
Endocr Connect. 2020 Jan;9(1):63-73. doi: 10.1530/EC-19-0522.
10
Use of Acupuncture in Overweight/Obese Women with Polycystic Ovary Syndrome.针灸在超重/肥胖多囊卵巢综合征女性中的应用。
Med Acupunct. 2019 Oct 1;31(5):267-268. doi: 10.1089/acu.2019.1375. Epub 2019 Oct 17.